We have observed
18 EP applications
Stephen John Eves Evans
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 22, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
BACTERICIDAL ANTIBODY ASSAYS TO ASSESS IMMUNOGENICITY AND POTENCY OF MENINGOCOCCAL CAPSULAR SACCHARIDE VACCINES
COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT
FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE
PILUS PROTEINS AND COMPOSITIONS
Fermentation processes for cultivating streptococci and purification processes for obtaining CPS therefrom
OUTER MEMBRANE VESICLES
CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE
Polysaccharides produced by CPSC mutants
HYBRID POLYPEPTIDES INCLUDING MENINGOCOCCAL FHBP SEQUENCES
GENERIC ASSAYS FOR DETECTION OF MAMMALIAN REOVIRUS
MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES
PURIFICATION OF SECRETED POLYSACCHARIDES FROM S. AGALACTIAE
CARRIER MOLECULE FOR ANTIGENS
PURIFICATION OF STREPTOCOCCAL CAPSULAR POLYSACCHARIDE